2026 NPPES data Optometrist NPI 1801277371 O.D.
Verify on CMS →

JEFFREY BINSTOCK, O.D.

Optometrist in REDMOND, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
206
Medicare Part D claims · 61 beneficiaries · Optometrist avg: 257
Generic prescribing
32%
generic claims · 68% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$96.55
5 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: JEFFREY BINSTOCK, O.D. is a Optometrist ([object Object]) practicing in REDMOND, Washington with a Medicare Part D prescribing footprint of 206 claims across 61 beneficiaries — 68% brand-name prescribing . Industry payments of $96.55 across 5 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: JEFFREY BINSTOCK, O.D. filed 206 Medicare Part D claims in 2023 across REDMOND, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

JEFFREY BINSTOCK, O.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 06/10/2015

NPI 1801277371

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

206 20% vs specialty avg

2023 prescription claims

Specialty avg: 257

Specialty distribution in Washington

How Optometrist compares to other specialties among Washington providers

Washington providers

Optometrist share within Washington

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Optometrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Optometrist ABMS/AOA estimate

Est. board-certified rate (Optometrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Optometrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JEFFREY BINSTOCK, O.D. is a Optometrist provider practicing in REDMOND, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O.D.. NPI: 1801277371. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JEFFREY BINSTOCK, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 12377 137TH PL NE UNIT 130, REDMOND, WA, 98052, with a listed phone of (425) 885-3574. NPI 1801277371 was issued on 06/10/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BINSTOCK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 206 prescription claims written by this provider, covering 61 Medicare beneficiaries and totaling roughly $147K in drug spend, split 68% brand-name and 32% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12377 137TH PL NE UNIT 130
REDMOND, WA 98052

Provider Details

NPI 1801277371
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 06/10/2015

Hospital and facility affiliations

Facilities where JEFFREY BINSTOCK, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

JEFF BINSTOCK DVM OD FAAO PLLC
REDMOND, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JEFFREY BINSTOCK, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$97

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to JEFFREY BINSTOCK, O.D.. To verify JEFFREY BINSTOCK, O.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

JEFFREY BINSTOCK, O.D. — brand share 68.0%
Specialty average (est.)

68% brand-name claims vs 32% generic, on 206 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

206
Total Claims
$147K
Total Drug Cost
61
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
413
Total Day Supply
11,936
Brand vs Generic
68% brand / 32% generic
Brand Drug Cost
$138K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
0.82
Gender Split
79% female / 21% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
50
Restasis
Cyclosporine
48
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
14
Loteprednol Etabonate
13
Lotemax Sm
Loteprednol Etabonate
12
Lumigan
Bimatoprost
12
Xiidra
Lifitegrast
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How JEFFREY BINSTOCK, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

JEFFREY BINSTOCK, O.D.'s 206 claims are below the specialty average of 257.

Nearby Optometrist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as BINSTOCK.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JEFFREY BINSTOCK, O.D.'s specialty?
JEFFREY BINSTOCK, O.D. specializes in Optometrist and practices in REDMOND, Washington. Credentials: O.D..
How much does JEFFREY BINSTOCK, O.D. prescribe under Medicare Part D?
In 2023, JEFFREY BINSTOCK, O.D. wrote 206 Medicare Part D claims totaling $147K in drug costs for 61 beneficiaries.
Where is JEFFREY BINSTOCK, O.D. located?
JEFFREY BINSTOCK, O.D. is located at 12377 137TH PL NE UNIT 130, REDMOND, WA, 98052. Phone: (425) 885-3574.
What is JEFFREY BINSTOCK, O.D.'s NPI number?
JEFFREY BINSTOCK, O.D.'s National Provider Identifier (NPI) is 1801277371, issued on 06/10/2015.
Does JEFFREY BINSTOCK, O.D. prescribe more brand-name or generic drugs?
JEFFREY BINSTOCK, O.D.'s prescribing is 68% brand-name and 32% generic drugs by claim count, with $138K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does JEFFREY BINSTOCK, O.D. prescribe most often?
Based on 2023 Medicare Part D data, JEFFREY BINSTOCK, O.D.'s most frequently prescribed drugs include Latanoprost, Restasis, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JEFFREY BINSTOCK, O.D. accept Medicare?
JEFFREY BINSTOCK, O.D. appears in CMS Medicare data with 206 Part D claims and 61 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JEFFREY BINSTOCK, O.D.'s credentials?
JEFFREY BINSTOCK, O.D.'s NPI is 1801277371 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology